Inflammation & Allergy - Drug Targets (Discontinued)
Title: Editorial from Editor-in-Chief
Volume: 10 Issue: 4
Author(s): Kurt S. Zaenker
Affiliation:
Export Options
About this article
Cite this article as:
S. Zaenker Kurt, Editorial from Editor-in-Chief, Inflammation & Allergy - Drug Targets (Discontinued) 2011; 10 (4) . https://dx.doi.org/10.2174/187152811796117799
DOI https://dx.doi.org/10.2174/187152811796117799 |
Print ISSN 1871-5281 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4055 |
10
Related Articles
-
Red Cell Membrane Lipids in Hemoglobinopathies
Current Molecular Medicine Hyperglycemia Induced Changes in Liver: In vivo and In vitro Studies
Current Diabetes Reviews Small Molecular Inhibitors for the Treatment of Rheumatoid Arthritis: Progress so Far
Mini-Reviews in Medicinal Chemistry Hyaluronan Fragmentation During Inflammatory Pathologies: A Signal that Empowers Tissue Damage
Mini-Reviews in Medicinal Chemistry Serine Proteinase Inhibitors in the Skin: Role in Homeostasis and Disease
Current Protein & Peptide Science Non-Denaturing Solubilization of Inclusion Bodies
Current Pharmaceutical Biotechnology Exploring Anti-inflammatory Potential of Thiazolidinone Derivatives of Benzenesulfonamide via Synthesis, Molecular Docking and Biological Evaluation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Assessment of rhIL-11 by Validated SE-LC Method and its Correlation with RP-LC and CZE Methods
Current Pharmaceutical Analysis Beyond Cholesterol Lowering: Pleiotropic Effects of Bile Acid Binding Resins Against Cardiovascular Disease Risk Factors in Patients with Metabolic Syndrome
Current Vascular Pharmacology G Protein-Coupled Receptor Kinase 2 - a Feedback Regulator of Gq Pathway Signalling
Current Drug Targets - Immune, Endocrine & Metabolic Disorders A Role for TGF-β Signaling in Neurodegeneration: Evidence from Genetically Engineered Models
Current Alzheimer Research Effects of Secondhand Smoke on Thyroid Function
Inflammation & Allergy - Drug Targets (Discontinued) Chemical Space of FLT3 Inhibitors as Potential Anti-AML Drugs
Recent Patents on Anti-Cancer Drug Discovery Current and Emerging Strategies in Osteoporosis Management
Current Pharmaceutical Design Kinins as Therapeutic Agents in Cardiovascular and Renal Diseases
Current Pharmaceutical Design Editorial (Hot Topic: Coming Back to Nature: Plants as a Vital Source of Pharmaceutically Important Metabolites – Part II B)
Current Medicinal Chemistry The Possible Use of Terpene Compounds in DC Immunotherapy against Cancer
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Leukotrienes, Antileukotrienes and Asthma
Mini-Reviews in Medicinal Chemistry The Long Non-Coding RNAs in Neurodegenerative Diseases: Novel Mechanisms of Pathogenesis
Current Alzheimer Research Preface
Current Molecular Medicine